Back to search

Article

The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay device

2022-10-10

Abstract excerpt

<h4>Background: </h4> The rapid and accurate diagnosis of individuals with SARS-CoV-2 infection is an effective way to prevent and control the spread of COVID-19. Although the detection of SARS-CoV‐2 viral RNA by RT‐qPCR is the gold standard for COVID‐19 testing, the use of antigen-detecting rapid diagnostic tests (Ag-RDTs) is emerging as a complementary surveillance tool as Omicron case numbers skyrocket worldwid...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6c75299d-1e66-5897-889e-eecebfb80d34
DOI
10.21203/rs.3.rs-2106847/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay deviceDOI 10.21203/rs.3.rs-2106847/v1
Highly Specific Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Antigen for Accurate Diagnosis of COVID-19Semantic proximity
Development of Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Protein for COVID-19 Antigen DetectionSemantic proximity
Comparison of a prototype SARS-CoV-2 lateral flow immunoassay with the BinaxNOW™ COVID-19 Antigen CARDSemantic proximity
Development of Nucleocapsid-Specific Monoclonal Antibodies for SARS-CoV-2 and Their ELISA Diagnostics on an Automatic Microfluidic DeviceSemantic proximity
Development of a SARS-CoV-2 monoclonal antibody panel and its applicability as a reagent in high-throughput fluorescence reduction neutralization and immunohistochemistry assaysSemantic proximity
Exploratory study of antibody titers against SARS-CoV-2 using an indirect immunoperoxidase assay in COVID-19 patients and vaccinated volunteersSemantic proximity
Serological diagnostic kit of SARS-CoV-2 antibodies using CHO-expressed full-length SARS-CoV-2 S1 proteinsSemantic proximity
Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 InfectionSemantic proximity
SARS-CoV-2 antibody responses determine disease severity in COVID-19 infected individualsSemantic proximity
High-Specificity Targets in SARS-CoV-2 N Protein for Serological Antibody DetectionSemantic proximity
SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalenceSemantic proximity
Generation and characterization of a multi-functional panel of monoclonal antibodies for SARS-CoV-2 research and treatmentSemantic proximity
Select a neighboring publication to make it the new centre.